More SEC Filings
View Older Stories View Newer Stories-
Form SCHEDULE 13G NextCure, Inc. Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G Yarrow Bioscience, Inc. Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13D/A Better Home & Finance Filed by: Activant Ventures Advisors III, LLC
-
Form SCHEDULE 13G Rein Therapeutics, Inc. Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G/A General Fusion Group Filed by: MERUS GLOBAL INVESTMENTS, LLC
-
Form SCHEDULE 13G Research Alliance Corp Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G PLIANT THERAPEUTICS, Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G JATT II Acquisition Corp Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G Editas Medicine, Inc. Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G Cyclerion Therapeutics, Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G Boundless Bio, Inc. Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G Amanat Acquisition Corp. Filed by: ADAR1 Capital Management, LLC
-
Form SCHEDULE 13G Banzai International, Filed by: CP BF Lending, LLC
-
Form SCHEDULE 13G/A CNS Pharmaceuticals, Filed by: Ikarian Capital, LLC
-
Form 4 Q2 Holdings, Inc. For: Aug 13 Filed by: Price Jonathan
-
Form SCHEDULE 13G/A Connect Biopharma Holdin Filed by: Ikarian Capital, LLC
-
Form SCHEDULE 13G Quince Therapeutics, Filed by: Ikarian Capital, LLC
-
Form 144 Outset Medical, Inc. Filed by: Trigg Leslie
-
Form 144 Outset Medical, Inc. Filed by: Brottem John L.
-
Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: Ikarian Capital, LLC
-
Form 144 Outset Medical, Inc. Filed by: Gaeta Renee
-
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Ikarian Capital, LLC
-
Form SCHEDULE 13G InMed Pharmaceuticals Filed by: Ikarian Capital, LLC
-
Form SCHEDULE 13G/A Galera Therapeutics, Filed by: Ikarian Capital, LLC
-
Form 4 NEOGEN CORP For: Aug 14 Filed by: Moylan John Patrick
-
Form SCHEDULE 13G/A KAZIA THERAPEUTICS LTD Filed by: Ikarian Capital, LLC
-
Form 4 NEOGEN CORP For: Aug 14 Filed by: Ranalli Tamara A.
-
Form 4 NETLIST INC For: Aug 12 Filed by: SASAKI GAIL M
-
Form SCHEDULE 13G Yesway, Inc. Filed by: TRKLA THOMAS N.
-
Form SCHEDULE 13G/A EverCommerce Inc. Filed by: Remer Eric Richard
-
Form 4 NEOGEN CORP For: Aug 14 Filed by: Stacey Jennifer Evans
-
Form SCHEDULE 13G/A NextCure, Inc. Filed by: Ikarian Capital, LLC
-
Form 4 Outlook Therapeutics, For: Aug 14 Filed by: Jahr Robert Charles
-
Form 4 Lifeway Foods, Inc. For: Aug 12 Filed by: SMOLYANSKY EDWARD
-
Form 4 NEOGEN CORP For: Aug 14 Filed by: Riggsbee Richard Bryan
-
Form SCHEDULE 13G/A Pharvaris N.V. Filed by: GENERAL ATLANTIC, L.P.
-
Form 4 NEOGEN CORP For: Aug 14 Filed by: Nassif Mikheal
-
Form 4 Cue Biopharma, Inc. For: Aug 12 Filed by: Lin Shao-Lee
-
Form 144 Cue Biopharma, Inc. Filed by: Lin Shao-Lee
-
Form 4 CLEANSPARK, INC. For: Aug 13 Filed by: Monnig Taylor
-
Form 144 Kinetik Holdings Inc. Filed by: ISQ Global Fund II GP LLC
-
Form 144 CLEANSPARK, INC. Filed by: Monnig Taylor
-
Form 4 CLEANSPARK, INC. For: Aug 13 Filed by: Garrison Scott Eugene
-
Form 144 CLEANSPARK, INC. Filed by: Garrison Scott Eugene
-
Form 4 CLEANSPARK, INC. For: Aug 13 Filed by: Vecchiarelli Gary Anthony
-
Form SCHEDULE 13G/A Smart Share Global Ltd Filed by: Silver Point Capital L.P.
-
Form 144 CLEANSPARK, INC. Filed by: Vecchiarelli Gary Anthony
-
Form 4 CLEANSPARK, INC. For: Aug 13 Filed by: Schultz S. Matthew
-
Form SCHEDULE 13G Braemar Hotels & Resorts Filed by: ZAZOVE ASSOCIATES LLC
-
Form 144 CLEANSPARK, INC. Filed by: Schultz S. Matthew
